BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 22943930)

  • 1. Efficacy and tolerability of diphenyl-dimethyl-dicarboxylate plus garlic oil in patients with chronic hepatitis.
    Lee MH; Kim YM; Kim SG
    Int J Clin Pharmacol Ther; 2012 Nov; 50(11):778-86. PubMed ID: 22943930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Garlic oil and DDB, comprised in a pharmaceutical composition for the treatment of patients with viral hepatitis, prevents acute liver injuries potentiated by glutathione deficiency in rats.
    Park EY; Ki SH; Ko MS; Kim CW; Lee MH; Lee YS; Kim SG
    Chem Biol Interact; 2005 Jun; 155(1-2):82-96. PubMed ID: 15950962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels.
    Cheong JY; Kim DJ; Hwang SG; Yang JM; Kim YB; Park YN; Cho SW
    Liver Int; 2011 Oct; 31(9):1352-8. PubMed ID: 21745311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDB treatment of patients with chronic hepatitis.
    Huber R; Hockenjos B; Blum HE
    Hepatology; 2004 Jun; 39(6):1732-3. PubMed ID: 15185315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Differential liver histopathological features of chronic HBV infection patients with normal and mildly elevated serum ALT].
    Ying RS; Yang Z; Chen YY; Yang KL; Xiao YH; Wu LJ; Fan HM
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):585-8. PubMed ID: 23207151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral silymarin for chronic hepatitis C - a retrospective analysis comparing three dose regimens.
    Huber R; Futter I; Lüdtke R
    Eur J Med Res; 2005 Feb; 10(2):68-70. PubMed ID: 15817425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Magnesium isoglycyrrhizinate in the treatment of chronic liver diseases: a randomized, double-blind, multi-doses, active drug controlled, multi-center study].
    Mao YM; Zeng MD; Chen Y; Chen CW; Fu QC; Cai X; Wu SM; Chen YG; Sun Y; Li J; Sui YH; Zhao W; Lu LG; Cao AP; Chen HZ
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):847-51. PubMed ID: 19958646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigation of oxidative stress and antioxidant defense in patients with hepatitis B virus infection and the effect of interferon-alpha plus lamivudine combination therapy on oxidative stress].
    Acar A; Görenek L; Aydin A; Eyigün CP; Eken A; Sayal A; Pahsa A
    Mikrobiyol Bul; 2009 Jul; 43(3):411-23. PubMed ID: 19795616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: results of a prospective, double-blind, placebo-randomized study.
    Cadranel JF; Di Martino V; Dorent R; Bernard B; Hoang C; Myara A; Pauwels A; Ghoussoub JJ; Perrin M; Grippon P; Thabut D; Trivin F; Huraux JM; Gandjbakhch I; Opolon P; Lunel F
    Transplantation; 2003 Apr; 75(7):977-82. PubMed ID: 12698083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison on the efficacy and safety of biphenyl dimethyl dicarboxylate and ursodeoxycholic acid in patients with abnormal alanine aminotransferase: multicenter, double-blinded, randomized, active-controlled clinical trial].
    Lee SH; Cheon GJ; Kim HS; Kim YD; Kim SG; Kim YS; Jeong SW; Jang JY; Kim BS
    Korean J Gastroenterol; 2014 Jul; 64(1):31-9. PubMed ID: 25073669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Silybum marianum play a role in the treatment of chronic hepatitis C?
    Torres M; Rodríguez-Serrano F; Rosario DJ; Rodríguez-Perez F; Toro DH
    P R Health Sci J; 2004 Jun; 23(2 Suppl):69-74. PubMed ID: 16929590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine deaminase activity in serum of patients with hepatitis -- a useful tool in monitoring clinical status.
    Kaya S; Cetin ES; Aridogan BC; Arikan S; Demirci M
    J Microbiol Immunol Infect; 2007 Aug; 40(4):288-92. PubMed ID: 17712462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis.
    Fabrizi F; Lunghi G; Finazzi S; Colucci P; Pagano A; Ponticelli C; Locatelli F
    Am J Kidney Dis; 2001 Nov; 38(5):1009-15. PubMed ID: 11684554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized double-blind placebo-controlled study of lamivudine in the treatment of patients with chronic hepatitis B virus infection.
    Yao G; Wang B; Cui Z; Yao J; Zeng M
    Chin Med J (Engl); 1999 May; 112(5):387-91. PubMed ID: 11593504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary amino acid taurine ameliorates liver injury in chronic hepatitis patients.
    Hu YH; Lin CL; Huang YW; Liu PE; Hwang DF
    Amino Acids; 2008 Aug; 35(2):469-73. PubMed ID: 17690950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial: the efficacy and safety of oral PF-03491390, a pancaspase inhibitor - a randomized placebo-controlled study in patients with chronic hepatitis C.
    Shiffman ML; Pockros P; McHutchison JG; Schiff ER; Morris M; Burgess G
    Aliment Pharmacol Ther; 2010 May; 31(9):969-78. PubMed ID: 20163376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
    Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B: a double-blind, placebo-controlled trial.
    Chan HL; Wang H; Niu J; Chim AM; Sung JJ
    Antivir Ther; 2007; 12(3):345-53. PubMed ID: 17591024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C.
    van Rossum TG; Vulto AG; Hop WC; Schalm SW
    Am J Gastroenterol; 2001 Aug; 96(8):2432-7. PubMed ID: 11513186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.